Aims and objectives

The Ghent Auditory Science Platform (GASP) consortium has identified a number of challenges for the road ahead in hearing research:

  • biological strategies for use in the inner ear: gene therapy, stem-cell therapy, and molecular therapy;
  • auditory nerve fiber (high-threshold) stimulation, resynchronizing, brain-computer interfacing;
  • stimulating brain plasticity (e.g. post deafness, tinnitus and/or decreased sound tolerances), also individualized interventions in therapy;
  • cochlear nerve sensing and brainstem processing (auditory processing on implanted chip);
  • neuro-acoustic phenotype determination allowing for personalized hearing deficit treatment when needed.